ID   GUC2D_HUMAN             Reviewed;        1103 AA.
AC   Q02846; Q6LEA7;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   02-NOV-2010, entry version 133.
DE   RecName: Full=Retinal guanylyl cyclase 1;
DE            Short=RETGC-1;
DE            EC=4.6.1.2;
DE   AltName: Full=Guanylate cyclase 2D, retinal;
DE   AltName: Full=Rod outer segment membrane guanylate cyclase;
DE            Short=ROS-GC;
DE   Flags: Precursor;
GN   Name=GUCY2D; Synonyms=CORD6, GUC1A4, GUC2D, RETGC, RETGC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   MEDLINE=93001163; PubMed=1356371; DOI=10.1016/0896-6273(92)90035-C;
RA   Shyjan A.W., de Sauvage F.J., Gillett N.A., Goeddel D.V., Lowe D.G.;
RT   "Molecular cloning of a retina-specific membrane guanylyl cyclase.";
RL   Neuron 9:727-737(1992).
RN   [2]
RP   SEQUENCE REVISION.
RA   Lowe D.G.;
RL   Submitted (JAN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Perrault I.;
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1009-1088.
RX   MEDLINE=95104866; PubMed=7806240; DOI=10.1006/geno.1994.1415;
RA   Oliveira L., Miniou P., Viegas-Pequignot E., Rozet J.-M., Dollfus H.,
RA   Pittler S.J.;
RT   "Human retinal guanylate cyclase (GUC2D) maps to chromosome 17p13.1.";
RL   Genomics 22:478-481(1994).
RN   [5]
RP   3D-STRUCTURE MODELING OF 871-1028.
RX   MEDLINE=98054247; PubMed=9391039; DOI=10.1073/pnas.94.25.13414;
RA   Liu Y., Ruoho A.E., Rao V.D., Hurley J.H.;
RT   "Catalytic mechanism of the adenylyl and guanylyl cyclases: modeling
RT   and mutational analysis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:13414-13419(1997).
RN   [6]
RP   VARIANT LCA1 SER-52.
RX   MEDLINE=97099458; PubMed=8944027; DOI=10.1038/ng1296-461;
RA   Perrault I., Rozet J.-M., Calvas P., Gerber S., Camuzat A.,
RA   Dollfus H., Chatelin S., Souied E., Ghazi I., Leowski C.,
RA   Bonnemaison M., le Paslier D., Frezal J., Dufier J.-L., Pittler S.,
RA   Munnich A., Kaplan J.;
RT   "Retinal-specific guanylate cyclase gene mutations in Leber's
RT   congenital amaurosis.";
RL   Nat. Genet. 14:461-464(1996).
RN   [7]
RP   VARIANT CORD6 837-ASP--MET-839.
RX   MEDLINE=98349989; PubMed=9683616; DOI=10.1086/301985;
RA   Perrault I., Rozet J.-M., Gerber S., Kelsell R.E., Souied E.,
RA   Cabot A., Hunt D.M., Munnich A., Kaplan J.;
RT   "A retGC-1 mutation in autosomal dominant cone-rod dystrophy.";
RL   Am. J. Hum. Genet. 63:651-654(1998).
RN   [8]
RP   VARIANTS CORD6 ASP-837 AND CYS-838.
RX   MEDLINE=98282246; PubMed=9618177; DOI=10.1093/hmg/7.7.1179;
RA   Kelsell R.E., Gregory-Evans K., Payne A.M., Perrault I., Kaplan J.,
RA   Yang R.-B., Garbers D.L., Bird A.C., Moore A.T., Hunt D.M.;
RT   "Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant
RT   cone-rod dystrophy.";
RL   Hum. Mol. Genet. 7:1179-1184(1998).
RN   [9]
RP   CHARACTERIZATION OF VARIANT LCA1 SER-565.
RX   MEDLINE=99105799; PubMed=9888789; DOI=10.1021/bi9824137;
RA   Duda T., Venkataraman V., Goraczniak R., Lange C., Koch K.-W.,
RA   Sharma R.K.;
RT   "Functional consequences of a rod outer segment membrane guanylate
RT   cyclase (ROS-GC1) gene mutation linked with Leber's congenital
RT   amaurosis.";
RL   Biochemistry 38:509-515(1999).
RN   [10]
RP   VARIANTS LCA1 TYR-105; PRO-325 AND SER-858.
RX   PubMed=11035546; DOI=10.1076/1381-6810(200009)21:3;1-Z;FT135;
RA   Dharmaraj S.R., Silva E.R., Pina A.-L., Li Y.Y., Yang J.M.,
RA   Carter C.R., Loyer M.K., El-Hilali H.K., Traboulsi E.K., Sundin O.K.,
RA   Zhu D.K., Koenekoop R.K., Maumenee I.H.;
RT   "Mutational analysis and clinical correlation in Leber congenital
RT   amaurosis.";
RL   Ophthalmic Genet. 21:135-150(2000).
RN   [11]
RP   VARIANT LCA1 PRO-954.
RX   PubMed=12365911;
RA   Koenekoop R.K., Fishman G.A., Iannaccone A., Ezzeldin H.,
RA   Ciccarelli M.L., Baldi A., Sunness J.S., Lotery A.J., Jablonski M.M.,
RA   Pittler S.J., Maumenee I.;
RT   "Electroretinographic abnormalities in parents of patients with Leber
RT   congenital amaurosis who have heterozygous GUCY2D mutations.";
RL   Arch. Ophthalmol. 120:1325-1330(2002).
RN   [12]
RP   VARIANTS CORD6 CYS-838 AND HIS-838, AND DISCUSSION OF PHENOTYPIC
RP   VARIABILITY.
RX   MEDLINE=22439680; PubMed=12552567; DOI=10.1002/humu.9109;
RA   Udar N., Yelchits S., Chalukya M., Yellore V., Nusinowitz S.,
RA   Silva-Garcia R., Vrabec T., Hussles Maumenee I., Donoso L.,
RA   Small K.W.;
RT   "Identification of GUCY2D gene mutations in CORD5 families and
RT   evidence of incomplete penetrance.";
RL   Hum. Mutat. 21:170-171(2003).
RN   [13]
RP   CHARACTERIZATION OF VARIANTS LCA1 TYR-105; PRO-325; SER-858 AND
RP   PRO-954.
RX   PubMed=15123990;
RA   Tucker C.L., Ramamurthy V., Pina A.-L., Loyer M., Dharmaraj S., Li Y.,
RA   Maumenee I.H., Hurley J.B., Koenekoop R.K.;
RT   "Functional analyses of mutant recessive GUCY2D alleles identified in
RT   Leber congenital amaurosis patients: protein domain comparisons and
RT   dominant negative effects.";
RL   Mol. Vis. 10:297-303(2004).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-328; ASP-431; MET-507; GLU-693;
RP   SER-701 AND HIS-782.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Probably plays a specific functional role in the rods
CC       and/or cones of photoreceptors. It may be the enzyme involved in
CC       the resynthesis of cGMP required for recovery of the dark state
CC       after phototransduction.
CC   -!- CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.
CC   -!- ENZYME REGULATION: Activated by GCAP-1; inhibited by calcium.
CC   -!- INTERACTION:
CC       P06241:FYN; NbExp=1; IntAct=EBI-1756902, EBI-515315;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Retina. Localized exclusively in the nuclei
CC       and inner segments of the rod and cone photoreceptor cells.
CC   -!- DISEASE: Defects in GUCY2D are the cause of Leber congenital
CC       amaurosis type 1 (LCA1) [MIM:204000]. LCA designates a clinically
CC       and genetically heterogeneous group of childhood retinal
CC       degenerations, generally inherited in an autosomal recessive
CC       manner. Affected infants have little or no retinal photoreceptor
CC       function as tested by electroretinography. LCA represents the most
CC       common genetic cause of congenital visual impairment in infants
CC       and children.
CC   -!- DISEASE: Defects in GUCY2D are the cause of cone-rod dystrophy
CC       type 6 (CORD6) [MIM:601777]. CORDs are inherited retinal
CC       dystrophies belonging to the group of pigmentary retinopathies.
CC       CORDs are characterized by retinal pigment deposits visible on
CC       fundus examination, predominantly in the macular region, and
CC       initial loss of cone photoreceptors followed by rod degeneration.
CC       This leads to decreased visual acuity and sensitivity in the
CC       central visual field, followed by loss of peripheral vision.
CC       Severe loss of vision occurs earlier than in retinitis pigmentosa.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl
CC       cyclase family.
CC   -!- SIMILARITY: Contains 1 guanylate cyclase domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Mutations of the GUCY2D gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.com/sci-news/gcmut.htm";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/GUCY2D";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M92432; AAA60547.1; -; mRNA.
DR   EMBL; AJ222657; CAA10914.1; -; Genomic_DNA.
DR   EMBL; L26921; AAA60366.1; -; Genomic_DNA.
DR   IPI; IPI00027242; -.
DR   PIR; JH0717; JH0717.
DR   RefSeq; NP_000171.1; -.
DR   UniGene; Hs.592109; -.
DR   PDB; 1AWL; Model; -; A/B=871-1028.
DR   PDBsum; 1AWL; -.
DR   ProteinModelPortal; Q02846; -.
DR   SMR; Q02846; 557-840, 874-1060.
DR   IntAct; Q02846; 1.
DR   MINT; MINT-7241905; -.
DR   STRING; Q02846; -.
DR   PhosphoSite; Q02846; -.
DR   PeptideAtlas; Q02846; -.
DR   PRIDE; Q02846; -.
DR   Ensembl; ENST00000254854; ENSP00000254854; ENSG00000132518.
DR   GeneID; 3000; -.
DR   KEGG; hsa:3000; -.
DR   NMPDR; fig|9606.3.peg.13079; -.
DR   UCSC; uc002gjt.2; human.
DR   CTD; 3000; -.
DR   GeneCards; GC17P007846; -.
DR   H-InvDB; HIX0202505; -.
DR   HGNC; HGNC:4689; GUCY2D.
DR   MIM; 204000; phenotype.
DR   MIM; 600179; gene.
DR   MIM; 601777; phenotype.
DR   Orphanet; 1872; Cone rod dystrophy.
DR   Orphanet; 65; Congenital Leber amaurosis.
DR   PharmGKB; PA187; -.
DR   eggNOG; prNOG08287; -.
DR   HOGENOM; HBG714686; -.
DR   HOVERGEN; HBG098487; -.
DR   InParanoid; Q02846; -.
DR   OMA; LGPWACD; -.
DR   OrthoDB; EOG9BP3X3; -.
DR   PhylomeDB; Q02846; -.
DR   BRENDA; 4.6.1.2; 247.
DR   Pathway_Interaction_DB; cone_pathway; Visual signal transduction: Cones.
DR   Pathway_Interaction_DB; rhodopsin_pathway; Visual signal transduction: Rods.
DR   NextBio; 11896; -.
DR   ArrayExpress; Q02846; -.
DR   Bgee; Q02846; -.
DR   CleanEx; HS_GUCY2D; -.
DR   Genevestigator; Q02846; -.
DR   GermOnline; ENSG00000132518; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005640; C:nuclear outer membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; TAS:ProtInc.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0004872; F:receptor activity; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007168; P:receptor guanylyl cyclase signaling pathway; TAS:ProtInc.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR011645; Haem_no_assoc-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   Gene3D; G3DSA:3.30.70.1230; A/G_cyclase; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00211; Guanylate_cyc; 1.
DR   Pfam; PF07701; HNOBA; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   SMART; SM00044; CYCc; 1.
DR   SUPFAM; SSF55073; A/G_cyclase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cGMP biosynthesis; Complete proteome;
KW   Cone-rod dystrophy; Disease mutation; Disulfide bond; Glycoprotein;
KW   GTP-binding; Leber congenital amaurosis; Lyase; Membrane;
KW   Nucleotide-binding; Polymorphism; Sensory transduction; Signal;
KW   Transmembrane; Transmembrane helix; Vision.
FT   SIGNAL        1     51       Potential.
FT   CHAIN        52   1103       Retinal guanylyl cyclase 1.
FT                                /FTId=PRO_0000012381.
FT   TOPO_DOM     52    462       Extracellular (Potential).
FT   TRANSMEM    463    487       Helical; (Potential).
FT   TOPO_DOM    488   1103       Cytoplasmic (Potential).
FT   DOMAIN      525    808       Protein kinase.
FT   DOMAIN      880   1010       Guanylate cyclase.
FT   CARBOHYD    297    297       N-linked (GlcNAc...) (Potential).
FT   DISULFID    449    449       Interchain (Probable).
FT   DISULFID    457    457       Interchain (Probable).
FT   VARIANT      52     52       A -> S (in LCA1; could be a rare
FT                                polymorphism).
FT                                /FTId=VAR_003435.
FT   VARIANT     105    105       C -> Y (in LCA1; does not affect basal
FT                                activity; reduces GCAP-1 induced
FT                                activity).
FT                                /FTId=VAR_023770.
FT   VARIANT     325    325       L -> P (in LCA1; does not affect basal
FT                                activity; reduces GCAP-1 induced
FT                                activity).
FT                                /FTId=VAR_023771.
FT   VARIANT     328    328       A -> V (in dbSNP:rs56280231).
FT                                /FTId=VAR_042229.
FT   VARIANT     331    331       R -> S (in dbSNP:rs34596269).
FT                                /FTId=VAR_049254.
FT   VARIANT     362    362       A -> S (in LCA1).
FT                                /FTId=VAR_009129.
FT   VARIANT     431    431       G -> D (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042230.
FT   VARIANT     507    507       V -> M.
FT                                /FTId=VAR_042231.
FT   VARIANT     565    565       F -> S (in LCA1; loss of activity).
FT                                /FTId=VAR_009131.
FT   VARIANT     573    573       I -> V (in LCA1).
FT                                /FTId=VAR_009130.
FT   VARIANT     602    602       R -> W (in dbSNP:rs34331388).
FT                                /FTId=VAR_049255.
FT   VARIANT     693    693       A -> E (in dbSNP:rs35146471).
FT                                /FTId=VAR_042232.
FT   VARIANT     701    701       P -> S (in LCA1; dbSNP:rs34598902).
FT                                /FTId=VAR_009132.
FT   VARIANT     722    722       R -> W (in dbSNP:rs34331388).
FT                                /FTId=VAR_049256.
FT   VARIANT     782    782       L -> H (rare polymorphism;
FT                                dbSNP:rs8069344).
FT                                /FTId=VAR_009133.
FT   VARIANT     837    839       ERT -> DCM (in CORD6).
FT                                /FTId=VAR_003438.
FT   VARIANT     837    837       E -> D (in CORD6; dbSNP:rs28933695).
FT                                /FTId=VAR_003436.
FT   VARIANT     838    838       R -> C (in CORD6).
FT                                /FTId=VAR_003437.
FT   VARIANT     838    838       R -> H (in CORD6).
FT                                /FTId=VAR_015373.
FT   VARIANT     858    858       P -> S (in LCA1; severely impairs basal
FT                                and GCAP-1 induced activity).
FT                                /FTId=VAR_009134.
FT   VARIANT     954    954       L -> P (in LCA1; severely impairs basal
FT                                and GCAP-1 induced activity).
FT                                /FTId=VAR_009135.
FT   STRAND      882    885
FT   HELIX       888    892
FT   STRAND      896    898
FT   HELIX       899    902
FT   HELIX       904    913
FT   TURN        914    917
FT   STRAND      918    922
FT   STRAND      934    936
FT   HELIX       944    947
FT   HELIX       949    966
FT   STRAND      991    993
FT   STRAND      998   1000
FT   HELIX      1001   1004
FT   HELIX      1005   1007
FT   TURN       1008   1011
FT   STRAND     1015   1017
FT   HELIX      1022   1025
SQ   SEQUENCE   1103 AA;  120059 MW;  28631557E7CBDFA4 CRC64;
     MTACARRAGG LPDPGLCGPA WWAPSLPRLP RALPRLPLLL LLLLLQPPAL SAVFTVGVLG
     PWACDPIFSR ARPDLAARLA AARLNRDPGL AGGPRFEVAL LPEPCRTPGS LGAVSSALAR
     VSGLVGPVNP AACRPAELLA EEAGIALVPW GCPWTQAEGT TAPAVTPAAD ALYALLRAFG
     WARVALVTAP QDLWVEAGRS LSTALRARGL PVASVTSMEP LDLSGAREAL RKVRDGPRVT
     AVIMVMHSVL LGGEEQRYLL EAAEELGLTD GSLVFLPFDT IHYALSPGPE ALAALANSSQ
     LRRAHDAVLT LTRHCPSEGS VLDSLRRAQE RRELPSDLNL QQVSPLFGTI YDAVFLLARG
     VAEARAAAGG RWVSGAAVAR HIRDAQVPGF CGDLGGDEEP PFVLLDTDAA GDRLFATYML
     DPARGSFLSA GTRMHFPRGG SAPGPDPSCW FDPNNICGGG LEPGLVFLGF LLVVGMGLAG
     AFLAHYVRHR LLHMQMVSGP NKIILTVDDI TFLHPHGGTS RKVAQGSRSS LGARSMSDIR
     SGPSQHLDSP NIGVYEGDRV WLKKFPGDQH IAIRPATKTA FSKLQELRHE NVALYLGLFL
     ARGAEGPAAL WEGNLAVVSE HCTRGSLQDL LAQREIKLDW MFKSSLLLDL IKGIRYLHHR
     GVAHGRLKSR NCIVDGRFVL KITDHGHGRL LEAQKVLPEP PRAEDQLWTA PELLRDPALE
     RRGTLAGDVF SLAIIMQEVV CRSAPYAMLE LTPEEVVQRV RSPPPLCRPL VSMDQAPVEC
     ILLMKQCWAE QPELRPSMDH TFDLFKNINK GRKTNIIDSM LRMLEQYSSN LEDLIRERTE
     ELELEKQKTD RLLTQMLPPS VAEALKTGTP VEPEYFEQVT LYFSDIVGFT TISAMSEPIE
     VVDLLNDLYT LFDAIIGSHD VYKVETIGDA YMVASGLPQR NGQRHAAEIA NMSLDILSAV
     GTFRMRHMPE VPVRIRIGLH SGPCVAGVVG LTMPRYCLFG DTVNTASRME STGLPYRIHV
     NLSTVGILRA LDSGYQVELR GRTELKGKGA EDTFWLVGRR GFNKPIPKPP DLQPGSSNHG
     ISLQEIPPER RRKLEKARPG QFS
//
